Teva, Boehringer Trim 'Frankensteinian' Aggrenox Claims
By Michael Lipkin ( March 23, 2015, 8:15 PM EDT) -- A Connecticut judge on Monday kept intact most federal claims against Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. alleging a pay-for-delay scheme over a generic version of stroke drug Aggrenox but gutted a "hodgepodge" of state claims the judge compared to Frankenstein's monster....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.